Page last updated: 2024-08-23

nigericin and Cancer of Nasopharynx

nigericin has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bei, JX; Chen, LZ; Deng, CC; Feng, FT; Feng, QS; Hu, WR; Liang, Y; Wu, MS; Zeng, YX	1

Other Studies

1 other study(ies) available for nigericin and Cancer of Nasopharynx

Article	Year
Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma. The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:9 Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cell Movement; Cisplatin; Down-Regulation; Drug Synergism; Humans; Immunohistochemistry; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplastic Stem Cells; Nigericin; Polycomb Repressive Complex 1; Random Allocation; Xenograft Model Antitumor Assays	2013

Article

Year

Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.

The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:9

Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cell Movement; Cisplatin; Down-Regulation; Drug Synergism; Humans; Immunohistochemistry; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplastic Stem Cells; Nigericin; Polycomb Repressive Complex 1; Random Allocation; Xenograft Model Antitumor Assays

2013